LinkedIn is a great networking tool that just keeps getting better every year. One nice feature is the ability to create “groups” (which can be either public or private) – we’ve assembled several for our pharma colleagues. -> 1. The newest is Pharma Talent, for folks inside life sciences companies who have been displaced/downsized. Joining [...]
Archive for June, 2010
Impactiviti’s LinkedIn Groups for Pharma
Posted in Pharma, Pharmaceutical, Training, Training Needs, Web on June 29, 2010 |
Subscribe to: Impactiviti Connection (daily pharma news)
Posted in Impactiviti, Pharma, Pharma News, Pharmaceutical, Recommendations on June 23, 2010 |
For some time, I’ve been posting daily pharmaceutical industry news, resources, links of interest, jobs (+ some fun stuff!) here on the Impactiviti blog. Now, we’re going to make it more convenient for you. We’ve merged Impactiviti Daily with the periodic Impactiviti e-newsletter to give you Impactiviti Connection – an (almost) daily collection of great [...]
Conference Re-cap: SPBT 2010
Posted in Pharma, Pharmaceutical, SPBT, Training on June 22, 2010 | 1 Comment »
I recently had the pleasure of attending the annual Society of Pharmaceutical and Biotech Trainers (SPBT) Conference in Orlando. For those not involved in SPBT, this is a society made up of (sales) training professionals across the spectrum of pharmaceutical, biotech, and medical device companies. While the conference structure has slightly morphed over time, it [...]
Sex Pills
Posted in Boehringer Ingelheim, FDA, Medicine, Pharma, Pharmaceutical, tagged Boehringer Ingelheim, female sexual desire, female Viagra, flibanserin, sex on June 18, 2010 | 2 Comments »
One of this week’s major news items in the world of pharma is the less-than-enthusiastic response of an FDA panel to Boehringer-Ingelheim’s experimental “sexual desire for women” pill, flibanserin. I believe the quest for a “female Viagra” (an inaccurate parallel, by the way) is fundamentally misguided. Here’s why: There’s a big difference between sexual function [...]
Impactiviti Daily 061710 Top Pharma News
Posted in Boehringer Ingelheim, Eli Lilly, Pharma, Pharma News, Pharmaceutical, Sanofi-Aventis, Top News on June 17, 2010 |
***** TODAY’S NEWS: Boehringer‘s female sex pill: maybe not. The drug “failed to demonstrate a statistically significant improvement” in sexual desire, Food and Drug Administration staff said in a review released today. It was also linked to appendicitis, depression and loss of consciousness. Side effects led about 15 percent of women to stop treatment with [...]
Impactiviti Daily 061410 Top Pharma News
Posted in Avandia, Cephalon, Daiichi Sankyo, FDA, Glaxosmithkline, GSK, Healthcare, Novartis, Pharma, Pharma News, Pharmaceutical, Sanofi-Aventis, Top News, Training Needs on June 14, 2010 |
***** Had a great time last week at the SPBT conference. Planning to get out a summary post later this week… TODAY’S NEWS: Big news for Novartis: FDA panel unanimously recommends approval for oral MS drug – A Food and Drug Administration panel has unanimously backed the safety and effectiveness of Novartis’ multiple sclerosis treatment [...]
Impactiviti Daily – Top Pharma News 060410
Posted in Amgen, BMS, Bristol Myers, Novartis, Oncology, Pharma, Pharma News, Pharmaceutical, Sales training, Top News, Training Needs, tagged Amgen, Gleevec, glivec, nanosponge, Novartis, prolia, Sprycel, Tasigna on June 4, 2010 |
***** Impactiviti Daily will not be published next week, as I will be attending the annual Society of Pharmaceutical and Biotech Trainers conference (SPBT) in Orlando. TODAY’S NEWS: As the pre-ASCO news heats up, the big headline will be leukemia treatments – specifically, BMS‘ Sprycel and Novartis‘ Gleevec and Tasigna (just in – Tasigna shown [...]
Welcome!
Steve Woodruff
President, Impactiviti
Pharmaceutical Connection AgentConnect with Steve Woodruff
Testimonials
Free ebook! Getting Started with Social Networking
Subscribe!
Subscribe via e-mail
Subscribe to our e-newsletter
-
Bookmark
-
Recent Posts
- Why You Need to Build Your Network, Part 2
- Why You Need to Build Your Network, Part 1
- Fresh Pharma Jobs for Mid-April
- What Do I Want To Do When I Grow Up?
- The Myth of Corporate Job Security
- One Pharma Network You Need to Plug Into
- Mining for Gold, and Pharma Social Media
- Build Your Own Opportunity Network
- Vendor or Partner?
- Assess This!
-
Recent Comments
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
c
-
Pages
